Skip to main content
. Author manuscript; available in PMC: 2023 Feb 17.
Published in final edited form as: Mol Cell. 2021 Dec 28;82(4):728–740. doi: 10.1016/j.molcel.2021.12.001

Figure 3. Paradigm of persister cancer cells.

Figure 3.

Tumors are heterogenous by nature and composed of cancerous and non-cancerous cells. Notably, the latter includes cancer associated fibroblasts (CAFs) and immune cells constituting the tumor microenvironment (TEM). Therapy promotes evolution of the tumor composition towards the selection of cells that are refractory to treatment. This can lead to metastasis and cancer relapse.